Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diastereomeric Salt Formation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108069846B reveals a novel resolution method for cis-1-hydroxy-[1,1'-bis(cyclohexyl)]-2-carboxylic acid, eliminating precious metal catalysts for cost-effective pharmaceutical intermediate manufacturing.
Discover a novel dynamic resolution method for alpha-substituted-2-aminoacetamides achieving 98% yield. Ideal for pharmaceutical and agrochemical intermediate manufacturing.
Patent CN108473418A reveals a safer chiral resolution method for sulfonamide derivatives. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Patent CN105820113B reveals a novel resolution method for Crizotinib intermediates offering high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN1314336A details a novel two-component resolution method for high-purity (S)-(+)-ibuprofen, offering significant cost and time advantages for pharmaceutical manufacturing supply chains.
Novel resolution method for optically pure ephedrine using L-(-)-dibenzoyltartaric acid. High yield, recoverable agent, scalable industrial process.
Patent CN101659623A details a novel chemical resolution for leucine and isoleucine using DBTA, offering high purity and recyclable agents for reliable supply chains.
Patent CN107759466B details a water-based chiral resolution for S-(+)-Ketoprofen. Achieve high purity with reduced resolving agent costs and green manufacturing.
Patent CN101952252A details a tartaric acid resolution method for high-purity piperidine intermediates, offering significant cost reduction in API manufacturing and supply chain reliability.
Patent CN101910124A details a high-purity 3-aminopyrrolidine salt production via MPAA resolution, offering cost-effective aqueous processing for pharmaceutical intermediates.
Patent CN112939911A reveals a novel chiral resolution process for L-Corey lactone intermediates, offering high optical purity and scalable manufacturing for prostaglandin synthesis.
Patent CN109761886B reveals a superior resolution method for Argatroban intermediates using D-(+)-dibenzoyltartaric acid, achieving 99.1% optical purity and enhanced manufacturing efficiency.
Patent CN110177790B details a scalable resolution process for diazaspiro[4.5]decane derivatives, offering high enantiomeric excess and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN1894224A reveals a superior ethanol-based resolution process for Nefopam, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Advanced chemical resolution process for L-Valine and D-Valine using DBTA. Delivers >98% optical purity and scalable manufacturing for pharmaceutical intermediates.
Patent CN100336803C details a scalable resolution method for difluorophenylalanine, offering high purity and cost-effective supply chain solutions for pharma.
Patent CN109534957B details a scalable chemical resolution route for S-(-)-2-methyl-3-phenyl-1-propanol, offering significant cost reduction and supply chain stability for chiral intermediates.
Patent CN1197447A discloses a robust method for resolving racemates like selegiline and ephedrine using stable phenoxypropionic acid derivatives, offering high purity and scalable manufacturing advantages.
Patent CN100341850C details a novel chiral resolution method for demethylphencynonate salts, enabling >98% optical purity for anti-motion sickness API manufacturing with reduced costs.
Novel resolution method for S-indoline-2-carboxylic acid using amino acid esters. High purity, recyclable mother liquor, optimized for Perindopril synthesis.